Le 13 juin 2005

The opportunity of uncertainty (en anglais seulement)
– Alan. E. Winter, président et directeur général, Genome BC –

Currently Genome BC manages a $173 million genomics and proteomics research program that includes investments in 19 large-scale projects and five technology platforms. In addition, Genome BC’s communications, education and GE3LS activities provide a strong foundation such that its ventures are supported by a wide variety of stakeholders including scientists, universities, governments, industry, the media and the public.

Based on the results of the research program over the past four years, Genome BC has entered into a business planning process for the years 2005 to 2010 which is focused on translating the excellent research results into benefits for all sectors in life science including health, forestry, fisheries, agriculture, viticulture and the environment. As David Hall points out in the Guest Column in the summer issue of Signals, the ability to benefit from this translational research also depends on a strong life science industry in British Columbia.

Over the next five years, the people of Genome BC and those associated with the organization will build upon the achievements of the first four years. A Pathway to Success has been identified that involves continual development of both large-scale projects and platforms, and expansion of the organization’s expertise. By bringing worldwide attention to BC’s scientific excellence, Genome BC will strengthen its position in the Province; foster international projects; and increase its position as an important contributor to the global genomics and proteomics community.

The uncertainty surrounding the status of the current federal government and the role of that uncertainty in Genome BC funding are reminders that it is critical to seek new opportunities that may arise. Today’s organizations need to be more flexible and responsive, therefore as Genome BC-funded scientists continue to forge more international collaborations and meet with potential commercialization partners, Genome BC is increasingly cognizant of the need to identify potential partnerships and areas of common interest.

Very rarely is any Pathway to Success a straight line! Genome BC’s vision is sound, its partnerships are flourishing and growing, and collectively it is ready to face challenges that may arise in the coming months and years.

Sincerely,
Dr. Alan E. Winter,
President and CEO

The Summer 2005 edition of Signals is now available in both hard copy and electronic copy. If you would like to be added to the distribution list, please e-mail
info@genomebc.ca.

Retour